Skip to main content

Table 2

From: The development of a mini-array for estimating the disease state of gastric adenocarcinoma by array CGH

BAC ID Chrom. region Candidate Gene Frequency of DCNAs(%) Frequency of DCNAs(%) P-value*
Gain      
Node metastasis    Positive (n = 60) Negative (n = 23)  
225 2q24.32 TMEM132D 3 26 0.0005
1308 5q13.2 FCHO2, MGC13034 7 43 0.0005
491 16p13.11 PKD1P3 5 35 0.0006
884 19q13.32 N.i. 5 30 0.0006
Liver metastasis    Positive (n = 6) Negative (n = 77)  
1322 1p13.2 CHIA, C1orf88, OVGP1 43 3 <0.0001
1271 8p22 N.i. 67 13 0.0016
92 11p15 ST5 43 6 0.0006
Peritoneal dissemination    Positive (n = 19) Negative (n = 64)  
948 15q22.1 MYO1E, LDHAL6B 22 0 0.0002
155 Xp21.2 XK 35 5 0.0009
Histologic type    Diffuse (n = 42) Intestinal (n = 41)  
563 10p15.3 DIP2C 7 38 0.0011
911 10q24.2 SPFH1, CHUK, CWF19L1 0 23 0.0013
Loss      
Node metastasis    Positive (n = 60) Negative (n = 23)  
936 8p21.2 DOCK5, GNRH1, KCTD9, CDCA2 3 23 0.0023
1158 8p21.1 EXTL3 3 21 0.0023
878 13q31.2 SLITRK5 13 47 0.0007
Liver metastasis    Positive (n = 6) Negative (n = 77)  
877 1p32.3 LRP8, 50 5 0.0006
1386 7q35 CNTNAP2, 43 4 0.0001
309 21q22.3 HSF2BP, KIAA0179, 29 1 0.0002
Peritoneal dissemination    Positive (n = 19) Negative (n = 64)  
1407 3p26.3 CNTN6 33 6 0.0009
503 3p24.3 UBE2E1 32 6 0.0009
229 4q31.1 MAML3 44 5 <0.0001
Histologic type    Diffuse (n = 42) Intestinal (n = 41)  
1292 4q34.1 N.i. 17 53 0.0004
1393 5q33.2 TIMD4 15 48 0.0007
91 8p21.3 INTS10 0 24 0.0006
227 14q32.33 IGHV3-22 16 54 0.0001
1122 15q15.3 GANC, CAPN3 2 27 0.0003
1210 17q13.2 ATP2A3, ZZEF1 5 41 0.0001
  1. N.I.; not identified
  2. * χ2 test between two groups
  3. Ratios (log2) that exceed >0.25 are considered DNA copy number gains, and ratios (log2) that exceed <-0.25 are considered to be DNA copy number losses.